These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38891026)

  • 1. Cell-Based Therapy for Fibrosing Interstitial Lung Diseases, Current Status, and Potential Applications of iPSC-Derived Cells.
    Nakamura Y; Niho S; Shimizu Y
    Cells; 2024 May; 13(11):. PubMed ID: 38891026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
    Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.
    Takei R; Brown KK; Yamano Y; Kataoka K; Yokoyama T; Matsuda T; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Goto Y; Kondoh Y
    Respirology; 2022 May; 27(5):333-340. PubMed ID: 35293077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation by overexpression of c-MET in fibroblastic foci of usual interstitial pneumonia.
    Melocchi L; Cervi G; Sartori G; Gandolfi L; Jocollé G; Cavazza A; Rossi G
    Pathologica; 2023 Dec; 115(6):308-317. PubMed ID: 37812383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune mechanisms in fibrotic interstitial lung disease.
    Kamiya M; Carter H; Espindola MS; Doyle TJ; Lee JS; Merriam LT; Zhang F; Kawano-Dourado L; Sparks JA; Hogaboam CM; Moore BB; Oldham WM; Kim EY
    Cell; 2024 Jul; 187(14):3506-3530. PubMed ID: 38996486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic Criteria for the Diagnosis of Usual Interstitial Pneumonia vs Fibrotic Hypersensitivity Pneumonitis in Transbronchial Cryobiopsies.
    Churg A; Tazelaar H; Matej R; Vasakova MK; Stewart B; Patel D; Duarte E; Gomez Manjarres DC; Mehta HJ; Wright JL
    Mod Pathol; 2023 Sep; 36(9):100221. PubMed ID: 37236510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
    Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
    Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study.
    Röhrich M; Leitz D; Glatting FM; Wefers AK; Weinheimer O; Flechsig P; Kahn N; Mall MA; Giesel FL; Kratochwil C; Huber PE; Deimling AV; Heußel CP; Kauczor HU; Kreuter M; Haberkorn U
    J Nucl Med; 2022 Jan; 63(1):127-133. PubMed ID: 34272325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model.
    Schruf E; Schroeder V; Le HQ; Schönberger T; Raedel D; Stewart EL; Fundel-Clemens K; Bluhmki T; Weigle S; Schuler M; Thomas MJ; Heilker R; Webster MJ; Dass M; Frick M; Stierstorfer B; Quast K; Garnett JP
    FASEB J; 2020 Jun; 34(6):7825-7846. PubMed ID: 32297676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
    Ghadiri M; Young PM; Traini D
    Expert Opin Biol Ther; 2016; 16(3):375-87. PubMed ID: 26593230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis.
    Kletukhina S; Mutallapova G; Titova A; Gomzikova M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis.
    Takei R; Matsuda T; Fukihara J; Sasano H; Yamano Y; Yokoyama T; Kataoka K; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Kondoh Y
    Front Med (Lausanne); 2023; 10():1067149. PubMed ID: 37457568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).
    Joannes A; Voisin T; Morzadec C; Letellier A; Gutierrez FL; Chiforeanu DC; Le Naoures C; Guillot S; De Latour BR; Rouze S; Jaillet M; Crestani B; Wollin L; Jouneau S; Vernhet L
    Pulm Pharmacol Ther; 2023 Dec; 83():102267. PubMed ID: 37972706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis.
    Boesch M; Baty F; Brutsche MH; Tamm M; Roux J; Knudsen L; Gazdhar A; Geiser T; Khan P; Hostettler KE
    Respir Res; 2020 Jun; 21(1):165. PubMed ID: 32605572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis.
    Piotrowski WJ; Martusewicz-Boros MM; Białas AJ; Barczyk A; Batko B; Błasińska K; Boros PW; Górska K; Grzanka P; Jassem E; Jastrzębski D; Kaczyńska J; Kowal-Bielecka O; Kucharz E; Kuś J; Kuźnar-Kamińska B; Kwiatkowska B; Langfort R; Lewandowska K; Mackiewicz B; Majewski S; Makowska J; Miłkowska-Dymanowska J; Puścińska E; Siemińska A; Sobiecka M; Soroka-Dąda RA; Szołkowska M; Wiatr E; Ziora D; Śliwiński P
    Adv Respir Med; 2022 Oct; 90(5):425-450. PubMed ID: 36285980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.
    Wijsenbeek M; Kreuter M; Olson A; Fischer A; Bendstrup E; Wells CD; Denton CP; Mounir B; Zouad-Lejour L; Quaresma M; Cottin V
    Curr Med Res Opin; 2019 Nov; 35(11):2015-2024. PubMed ID: 31328965
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases.
    Wollin L; Distler JHW; Redente EF; Riches DWH; Stowasser S; Schlenker-Herceg R; Maher TM; Kolb M
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31285305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application.
    Zhao Y; Yan Z; Liu Y; Zhang Y; Shi J; Li J; Ji F
    Stem Cell Res Ther; 2021 Aug; 12(1):470. PubMed ID: 34420515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.